Elutia (ELUT) News Today $3.20 -0.01 (-0.31%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Elutia announces full U.S. commercial launch of EluProJanuary 14, 2025 | markets.businessinsider.comElutia Announces Full Launch of EluPro™ Following Strong Initial DemandJanuary 14, 2025 | markets.businessinsider.comElutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing PartnersJanuary 6, 2025 | markets.businessinsider.comElutia Inc. (ELUT)December 24, 2024 | finance.yahoo.comElutia (NASDAQ:ELUT) Trading Up 1.9% - Here's WhyElutia (NASDAQ:ELUT) Trading 1.9% Higher - Time to Buy?December 7, 2024 | marketbeat.comElutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.December 2, 2024 | finance.yahoo.comElutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 17, 2024 | uk.finance.yahoo.comQ3 2024 Elutia Inc Earnings CallNovember 15, 2024 | finance.yahoo.comElutia Inc. Reports Strong Q3 Results, Prepares for Major Product LaunchNovember 15, 2024 | markets.businessinsider.comElutia's (ELUT) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $10.00 price target on shares of Elutia in a report on Friday.November 15, 2024 | marketbeat.comElutia reports Q3 EPS (33c) vs (57c) last yearNovember 14, 2024 | markets.businessinsider.comElutia Inc. (ELUT) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comElutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025November 14, 2024 | markets.businessinsider.comElutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 13, 2024 | markets.businessinsider.comElutia (ELUT) Set to Announce Quarterly Earnings on ThursdayElutia (NASDAQ:ELUT) will be releasing earnings after the market closes on Thursday, November 14, Zacks reports.November 12, 2024 | marketbeat.comElutia Inc. (NASDAQ:ELUT) Short Interest UpdateElutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 108,200 shares, an increase of 7.4% from the September 30th total of 100,700 shares. Based on an average trading volume of 48,700 shares, the short-interest ratio is currently 2.2 days. Approximately 0.6% of the shares of the company are short sold.November 1, 2024 | marketbeat.comElutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30October 23, 2024 | globenewswire.comSILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia IncOctober 15, 2024 | finance.yahoo.comNantahala Capital Management LLC Grows Stock Position in Elutia Inc. (NASDAQ:ELUT)Nantahala Capital Management LLC lifted its stake in Elutia Inc. (NASDAQ:ELUT - Free Report) by 8.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,795,697 shares of the company's stock after buying an additional 14October 1, 2024 | marketbeat.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Declines By 30.1%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 70,500 shares, a decrease of 30.1% from the August 31st total of 100,800 shares. Based on an average trading volume of 69,100 shares, the short-interest ratio is currently 1.0 days. Currently, 0.4% of the shares of the stock are sold short.September 27, 2024 | marketbeat.comECU Health pioneers with FDA-approved EluPro BioEnvelope in pacemaker implantationSeptember 21, 2024 | msn.comElutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable DevicesSeptember 18, 2024 | globenewswire.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 10.9%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 100,800 shares, a decline of 10.9% from the August 15th total of 113,100 shares. Approximately 0.6% of the company's stock are sold short. Based on an average trading volume of 82,800 shares, the days-to-cover ratio is currently 1.2 days.September 17, 2024 | marketbeat.comAIGH Capital Management LLC Buys 1,260,750 Shares of Elutia Inc. (NASDAQ:ELUT)AIGH Capital Management LLC boosted its position in Elutia Inc. (NASDAQ:ELUT - Free Report) by 288.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,697,316 shares of the company's stocSeptember 9, 2024 | marketbeat.comElutia Celebrates First YearSeptember 6, 2024 | globenewswire.comElutia (NASDAQ:ELUT) Receives Overweight Rating from Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $10.00 target price on shares of Elutia in a research note on Friday.September 6, 2024 | marketbeat.comElutia Announces First Patient Implant of EluPro™, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and NeurostimulatorsSeptember 5, 2024 | globenewswire.comElutia to Participate in Upcoming Investor ConferencesSeptember 3, 2024 | globenewswire.comElutia Inc. (ELUT) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comElutia earnings missed by $0.78, revenue fell short of estimatesAugust 9, 2024 | investing.comElutia (NASDAQ:ELUT) Price Target Cut to $10.00Cantor Fitzgerald reduced their price objective on shares of Elutia from $11.00 to $10.00 and set an "overweight" rating for the company in a research note on Thursday.August 8, 2024 | marketbeat.comELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q2 2024August 7, 2024 | markets.businessinsider.comElutia Announces Second Quarter 2024 ResultsAugust 7, 2024 | finance.yahoo.comElutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross ProceedsAugust 1, 2024 | markets.businessinsider.comElutia Appoints Ryan Marques, Ph.D., MBA as Vice President of OperationsJuly 31, 2024 | globenewswire.comElutia (ELUT) Set to Announce Quarterly Earnings on WednesdayElutia (NASDAQ:ELUT) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports.July 31, 2024 | marketbeat.comBeat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in FocusJuly 22, 2024 | msn.comElutia to Present at the Emerging Growth Conference on Thursday, July 18July 11, 2024 | globenewswire.com7 Growth Stocks to Buy for Under $5 for Massive GainsJuly 11, 2024 | investorplace.comLake Street Capital Raises Elutia (NASDAQ:ELUT) Price Target to $10.00Lake Street Capital lifted their target price on Elutia from $5.00 to $10.00 and gave the company a "buy" rating in a research report on Friday.June 21, 2024 | marketbeat.comElutia (NASDAQ:ELUT) Price Target Raised to $11.00 at Cantor FitzgeraldCantor Fitzgerald lifted their target price on shares of Elutia from $5.00 to $11.00 and gave the company an "overweight" rating in a research note on Tuesday.June 18, 2024 | marketbeat.comElutia Announces $13.26 Million Registered Direct OfferingJune 17, 2024 | globenewswire.comElutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsJune 17, 2024 | globenewswire.comElutia Inc. (NASDAQ:ELUT) Short Interest Down 62.4% in MayElutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 7,300 shares, a drop of 62.4% from the May 15th total of 19,400 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 16,200 shares, the short-interest ratio is currently 0.5 days.June 12, 2024 | marketbeat.comElutia (NASDAQ:ELUT) Trading Up 1.7%Elutia (NASDAQ:ELUT) Trading Up 1.7%June 7, 2024 | marketbeat.comElutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024May 13, 2024 | finance.yahoo.comElutia (NASDAQ:ELUT) PT Lowered to $5.00 at Cantor FitzgeraldCantor Fitzgerald cut their price objective on Elutia from $6.00 to $5.00 and set an "overweight" rating on the stock in a research report on Friday.May 10, 2024 | marketbeat.comELUT Stock Earnings: Elutia Misses EPS, Beats Revenue for Q1 2024May 10, 2024 | investorplace.comElutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceMay 9, 2024 | finance.yahoo.comElutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024May 2, 2024 | finance.yahoo.com Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address ELUT Media Mentions By Week ELUT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELUT News Sentiment▼0.510.48▲Average Medical News Sentiment ELUT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELUT Articles This Week▼21▲ELUT Articles Average Week Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SIGA News Today TKNO News Today ZVRA News Today ATXS News Today PRTC News Today MBX News Today CYRX News Today KMDA News Today ABVX News Today KOD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELUT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elutia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elutia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELUT Stock Alerts